A/s Novo, 10% Owner at REATA PHARMACEUTICALS INC (RETA), sold 222,503 shares at $25.28 ($5.7M) on 2017-06-12, disclosed to the SEC on 2017-06-12.
Open-market sale of $5.7M RETA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.00 | 130,000 | $3.4M | 59.1% |
| 2 | $25.89 | 2,200 | $57K | 1.0% |
| 3 | $25.28 | 90,303 | $2.3M | 39.9% |
| Total | $25.71 avg | 222,503 | $5.7M | 100% |
| Filing → |
| APEN | SELL | 2017-05-11 | $582K | — | Filing → |
| OPHT | SELL | 2016-12-16 | $17.6M | — | Filing → |
| RARX | BUY | 2016-11-02 | $3.2M | — | Filing → |